Record Profit Growth Masks Competitive Squeeze Ahead

On paper, this is a blowout quarter. Revenue beats prior guidance by 7+ percentage points. Profit jumps 63%. Return ratios hit nine-quarter highs. But watch what management didn't do: raise guidance. That silence is the story. In a call buoyed by record delivery, the MD held AUM growth at 20-25% FY27 and ROA/ROE targets at 3% and 18% respectively. Why? Walk through the quarter's fine print, and the answer becomes clear—competitive intensity in gold loans has turned brutal, mortgage growth is lagging guidance, and technical delinquencies in the mortgage book demand Q3 validation.

Revenue of ₹719.4 Cr and PAT of ₹130.8 Cr are organic and clean—no MTM gain or exceptional item to reconcile. NII grew 5.2% QoQ to ₹404.8 Cr, a steady pace. Credit costs fell sharply to ₹27 Cr (0.6% annualized), down 20.5% QoQ and well below the 1% guidance floor. GNPA ticked up to 1.8% from 1.6% Q1, a 20 bps deterioration, driven entirely by a Stage II increase in mortgages from 2.7% to 3.6%—attributable, management says, to a new periodic-interest billing model rolled out in April. Gold loan GNPA stayed stable at 1.5%. The ROA expansion of 24 bps QoQ is the headline—the trajectory from 2.1% at start of FY27 to 2.8% now suggests the opex leverage and credit-cost discipline will hold.

Three material shifts from prior quarters emerge. First, gold loan competitive intensity is now explicitly 'very high'—a notch above earlier acknowledgment. Management noted competitors dropping yields 50+ bps per quarter; Fedbank dropped only 10 bps Q1-Q2, defending quality over volume. But the MD's language shifted to 'heightened,' signaling yield floors are being tested. Second, mortgage AUM growth at 13.5% YoY sits squarely below the 15-20% prior guidance range; while Q3/Q4 reacceleration is expected post-credit-cost stabilization, the 12% disbursement growth YoY suggests execution headwinds beyond seasonality. Third, Stage II delinquencies in mortgages jumped from 2.7% to 3.6% due to a periodic-interest billing model introduced in April; the technical framing is credible (gold Stage II stayed at 1.5%), but transition-risk remains until Q3 confirms normalization. Absent these three flags, guidance would have risen on the strong delivery. Instead, management held guidance—a rare instance of caution trumping momentum.

The market validated the earnings with a day-1 pop of +2.72% on 68.1% delivery, suggesting solid institutional buying into the news. Ownership data reveals a major FII re-entry: holdings rose from 0.66% in FY2026 Q4 to 9.31% by FY2027 Q1, a +8.65 percentage point surge—the sharpest quarterly jump in six quarters. This positioning into the large-cap NBFC basket reflected conviction ahead of or around the Q2 result. Bulk/block deals confirm the move: Nomura India Investment Fund purchased 1.44 Cr shares at ₹150 while True North Fund VI simultaneously sold the same quantity at the same price, a textbook institutional reallocation. DII holdings trimmed 7.93pp to 10.89%, a modest pullback from peak ownership. On valuation, the stock sits at ₹156.81, -12.14% from its all-time high of ₹178.48 and +31.7% off the 52-week low. Relative to SMA20 (₹152.73), SMA50 (₹154.57), and SMA200 (₹149.52), the stock trades above all three, signaling mid-term strength. RSI at 53.9 is neutral. The combined picture: FII re-entry into a post-result pop that has momentum, but valuation-savvy institutions positioning around the 20-25% AUM growth target rather than pricing in upside from here.